Suchergebnisse - M. Frigault

113 | CAN SALVAGE RADIOTHERAPY ACHIEVE DURABLE LOCAL CONTROL IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA POST‐CAR T FAILURE? von H. Ababneh, A. Ng, M. Frigault, C. Jacobson, C. Patel

Volltext

406 | COMBINING BISPECIFICS AND RADIATION FOR REL/REF HEMATOLOGIC MALIGNANCIES: FRIEND OR FOE? von H. Ababneh, A. Yee, N. Raje, M. Frigault, P. C. Johnson, C. Patel

Volltext

450 | 5‐5‐5 ABRT (ADAPTIVE BRIDGING RADIATION THERAPY)—ARTIFICIAL INTELLIGENCE ENTERS THE CAR (‐T) IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: UPDATED ANALYSIS von H. Ababneh, A. Ng, J. Wan, T. Walburn, L. Zhu, M. Bobić, P. C. Johnson, J. Bredtfeld, J. Leeman, J. Soumerai, J. Abramson, J. Barnes, R. Takvorian, M. Frigault, J. Pursley, C. Patel

Volltext

Enitociclib ( VIP152 ), venetoclax and prednisone in relapsed or refractory aggressive non‐Hodgkin lymphoma von Max J. Gordon, Rahul Lakhotia, Stefania Pittaluga, Svetlana D. Pack, Anna Marie Juanitez, Ahmed Hamdy, Amy J. Johnson, Melanie M. Frigault, Raquel Izumi, Mark Raffeld, Mark Roschewski, Wyndham H. Wilson, Christopher Melani

Volltext